Eastwood Bio-medical Canada Inc. (EBM)

[Claude233]

EASTWOOD BIO-MEDICAL CANADA ADDRESSES RECENT RISE IN SHARE PRICE

May 15, 2018 – Richmond, British Columbia – Eastwood Bio-medical Canada Inc. (TSX-V: EBM) (the “Company”) comments on the recent rise in share price. The shares traded to a high of $0.17 on May 15 compared to a low of $0.065 in April of 2018. Yunji Kim, President and CEO, stated that management of the Company is not aware of any new material information regarding the operations of the Company that might explain the recent price movement.

In April of 2018 the Company announced the launch of various new products, which is consistent with past announcements of ongoing operations. The Company also confirmed it had acquired manufacturing capabilities pursuant to the exercise of an option agreement that was previously announced in June of 2016.

The Company also announces that Louis Picco resigned from the Company’s Board of Directors on April 12, 2018, and the Company thanks him for his contributions.

For further information, please contact:

Eastwood Bio-medical Canada Inc.
Yunji Kim, President and Chief Officer
Telephone: [phone]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.